VR Logo

Lupin Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

38 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1983

Chairman: Manju D Gupta

Managing Director: Nilesh Deshbandhu Gupta

Group: Lupin

Listing: NSE: LUPIN, BSE: 500257

Headquarters: Mumbai, Maharashtra

Website: www.lupinworld.com

Key Facts

Market cap: R 30,495.83 Cr

Revenue (TTM): R 16,953.62 Cr

Earnings (TTM): R -369.14 Cr

Cash: R 3,097.06 Cr

Total Debt: R 8,496.15 Cr

Promoters' ownership: 46.93%

Liquidity: High

52 Week range: R 646.30 - 884.00

Face value: R2.00

Shares outstanding: 45,29,64,436

Stock Performance

Time Period Lupin S&P BSE Healthcare S&P BSE Mid Cap
YTD-11.985.783.18
1 month-9.030.69-2.39
3 months-12.816.014.79
1 Year-13.274.548.94
3 Years-22.61-2.534.50
5 Years-16.51-1.987.56
10 Years8.7111.389.32
As on 24-Feb-2020
Year Lupin S&P BSE Mid Cap S&P BSE Healthcare
2019-9.27-3.05-3.55
2018-4.59-13.31-5.89
2017-40.4848.130.49
2016-19.427.97-12.88
201528.557.4315.06
201455.8054.6947.43
201347.74-5.7322.55

Review & Analysis